KMPharmaceutical Corrects Treasury Stock Book Value to KRW 300.3 Million

PUBT · 2d ago
KMPharmaceutical Corrects Treasury Stock Book Value to KRW 300.3 Million
  • KMPharmaceutical on Oct. 23, 2026, corrected its post-acquisition treasury stock value to KRW 300.3 million.
  • The correction raised the value by KRW 300, fixing a typographical error in the Aug. 28 report.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KMPharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261023000225), on October 23, 2026, and is solely responsible for the information contained therein.